The global amlodipine market was valued at US$ 13.1 billion in 2024 and is projected to reach US$ 17.5 billion by 2032, exhibiting a CAGR of 3.8% during the forecast period (2024-2032). Historical trends indicate steady growth in demand, driven by the rising prevalence of hypertension and heart diseases. The increasing geriatric population and expanding healthcare access in emerging economies al..